세계의 세균성 폐렴 시장 보고서(2025년)

Bacterial Pneumonia Global Market Report 2025

US $ 4,490 ￦ 6,344,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,170,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,996,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세균성 폐렴 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 예측 기간의 성장은 의료 접근의 확대, 세균성 폐렴의 인지도 향상, 신규 치료제이나 백신의 진보 등입니다.

호흡기 질환의 유병률 증가는 세균성 폐렴 시장의 성장을 가속할 것으로 예측됩니다. 호흡기 질환의 이환율 상승에는 환경, 라이프 스타일, 인구 역학, 유전적 영향 등 여러 요인이 관여하고 있습니다. 박테리아 감염에 유리한 환경을 만들어 세균성 폐렴에 대한 감수성을 높입니다. 예를 들어, 2024년 3월 미국 정부 기관인 질병통제예방센터는 결핵 사례가 2022년 8,320건에서 2023년 9,615건으로 1,295건 증가했다고 보고했습니다.

세균성 폐렴 시장의 주요 기업은 면역 반응을 높이고 효과를 향상시키고 여러 박테리아 균주에 대한 광범위한 보호를 제공하기 위해 결합 백신 개발과 같은 백신 기술의 혁신을 강조합니다. 컨쥬게이트 백신은 약한 항원을 담체 단백질에 결합시킴으로써 면역력을 효과적으로 증가시킵니다. 예를 들어, 2024년 6월, 미국에 본사를 둔 제약 회사인 Merck & Co. 는 미국 식품의약국(FDA)으로부터 캡박시브(폐렴구균 21가 접합 백신)에 대한 승인을 받았습니다. 이 백신은 폐렴구균의 다양한 혈청형에 의해 유발되는 침습성 폐렴구균 감염 및 폐렴을 예방하기 위한 것으로, 특히 18세 이상의 성인을 대상으로 합니다. 이 백신의 도입은 세균성 폐렴 및 관련 폐렴구균 감염과 싸우는 데 있어 매우 중요한 역할을 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 세균성 폐렴 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 세균성 폐렴 시장 : 성장률 분석
• 세계의 세균성 폐렴 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 세균성 폐렴 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 세균성 폐렴 전체 시장(TAM)

제6장 시장 세분화

• 세계의 세균성 폐렴 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 지역사회획득성 폐렴(CAP)
• 병원획득성 폐렴(HAP)
• 세계의 세균성 폐렴 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 경구
• 피하
• 기타 투여 경로
• 세계의 세균성 폐렴 시장 : 치료법별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 백신
• 약물
• 세계의 세균성 폐렴 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 세균성 폐렴 시장 : 지역사회획득성 폐렴(CAP) 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 폐렴구균
• 헤모필루스 인플루엔자
• 마이코플라즈마 뉴모니아에
• 클라미디아 뉴모니아에
• 레지오넬라 뉴모필라균
• 세계의 세균성 폐렴 시장 : 병원획득성 폐렴(HAP) 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 녹농균
• 황색포도상구균
• 폐렴간균
• 아시네토박터 바우만니
• 엔테로박터 종균

제7장 지역별/국가별 분석

• 세계의 세균성 폐렴 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 세균성 폐렴 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 세균성 폐렴 시장 : 경쟁 구도
• 세균성 폐렴 시장 : 기업 프로파일
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
  • AstraZeneca PLC 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Novartis AG
• GSK plc
• bioMerieux SA
• Shionogi & Co. Ltd.
• Wockhardt Limited.
• Zai Lab Limited
• Innoviva Inc.
• Eagle Pharmaceuticals Inc.
• Basilea Pharmaceutica Ltd.
• Paratek Pharmaceuticals Inc.
• Cumberland Pharmaceuticals Inc.
• Melinta Therapeutics Inc.
• Nabriva Therapeutics plc.
• Clarametyx Biosciences Inc.
• Evopoint Biosciences Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 세균성 폐렴 시장(2029년) : 새로운 기회를 제공하는 국가
• 세균성 폐렴 시장(2029년) : 새로운 기회를 제공하는 부문
• 세균성 폐렴 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

KTH

영문 목차

영문목차

Bacterial pneumonia is a severe and potentially life-threatening respiratory condition caused by bacterial infections. It leads to inflammation and the accumulation of fluid or pus in the alveoli of the lungs, which disrupts normal oxygen exchange. This results in symptoms such as a severe cough, difficulty breathing, fever, chills, and chest pain, necessitating prompt medical intervention and appropriate treatment.

The primary types of bacterial pneumonia include community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). Community-acquired pneumonia (CAP) is a lung infection that develops outside healthcare settings and is typically caused by bacteria, viruses, or fungi, leading to lung inflammation and impaired gas exchange. Treatments are administered through oral, subcutaneous, or other methods and include vaccines and medications. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The bacterial pneumonia market research report is one of a series of new reports from The Business Research Company that provides bacterial pneumonia market statistics, including the bacterial pneumonia industry's global market size, regional shares, competitors with a bacterial pneumonia market share, detailed bacterial pneumonia market segments, market trends and opportunities, and any further data you may need to thrive in the bacterial pneumonia industry. This bacterial pneumonia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bacterial pneumonia market size has grown strongly in recent years. It will grow from $2.31 billion in 2024 to $2.52 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period can be attributed to increased awareness of respiratory diseases, a higher prevalence of bacterial infections, a growing geriatric population, increased healthcare expenditure, rapid urbanization, and rising air pollution levels.

The bacterial pneumonia market size is expected to see strong growth in the next few years. It will grow to $3.51 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period is driven by rising tobacco and alcohol consumption, increased government initiatives and funding, a growing prevalence of respiratory infections, rising antibiotic resistance, expanded healthcare access, greater awareness of bacterial pneumonia, and advancements in novel therapeutics and vaccines. Key trends include the development of innovative antibiotics, adoption of rapid diagnostic tools, advancements in vaccine technology, emergence of personalized medicine, integration of AI in disease management, and expanded use of monoclonal antibodies.

The increasing prevalence of respiratory diseases is anticipated to drive the growth of the bacterial pneumonia market. Respiratory diseases encompass medical conditions that disrupt breathing and gas exchange by affecting the organs and tissues of the lungs and airway systems. Several factors contribute to the rising incidence of respiratory diseases, including environmental, lifestyle, demographic, and genetic influences. These conditions heighten susceptibility to bacterial pneumonia by weakening the immune system and damaging lung tissues, thereby creating a favorable environment for bacterial infections. For example, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. Consequently, the growing prevalence of respiratory diseases is fueling the expansion of the bacterial pneumonia market.

Leading companies in the bacterial pneumonia market are emphasizing innovations in vaccine technology, such as the development of conjugate vaccines, to enhance immune response, improve efficacy, and offer broader protection against multiple bacterial strains. Conjugate vaccines work by linking a weak antigen to a carrier protein to effectively boost immunity. For instance, in June 2024, Merck & Co. Inc., a US-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine). This vaccine is designed to prevent invasive pneumococcal disease and pneumonia caused by various serotypes of Streptococcus pneumoniae, specifically targeting adults aged 18 and older. The introduction of this vaccine plays a crucial role in combating bacterial pneumonia and related pneumococcal infections.

In August 2022, GlaxoSmithKline plc, a UK-based pharmaceutical company, acquired Affinivax Inc. for $2.1 billion. Through this acquisition, GSK aims to strengthen its vaccine research and development by leveraging Affinivax's MAPS technology to create next-generation pneumococcal vaccines with expanded coverage and enhanced immunity. This advancement seeks to address unmet needs in bacterial pneumonia prevention. Affinivax Inc. is a US-based biotechnology company specializing in the development of vaccines for respiratory conditions.

Major players in the bacterial pneumonia market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca PLC, Novartis AG, GSK plc, bioMerieux SA, Shionogi & Co. Ltd., Wockhardt Limited., Zai Lab Limited, Innoviva Inc., Eagle Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics Inc., Nabriva Therapeutics plc., Clarametyx Biosciences Inc., Evopoint Biosciences Inc., Vaxcyte Inc., and Acurx Pharmaceuticals Inc.

North America was the largest region in the bacterial pneumonia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bacterial pneumonia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bacterial pneumonia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bacterial pneumonia market includes revenues earned by entities by providing services such as chest X-rays and computed tomography (CT) scans, rapid diagnostic tests, sputum cultures, and blood cultures. The market value includes the value of related goods sold by the service provider or included within the service offering. The bacterial pneumonia market consists of sales of broad-spectrum antibiotics, narrow-spectrum antibiotics, pneumococcal vaccines, mechanical ventilators, cough suppressants, and expectorants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bacterial Pneumonia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bacterial pneumonia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bacterial pneumonia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bacterial pneumonia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Community-Acquired Pneumonia (CAP); Hospital-Acquired Pneumonia (HAP)
• 2) By Route Of Administration: Oral; Subcutaneous; Other Route Of Administration
• 3) By Treatments: Vaccines; Drugs
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Community-Acquired Pneumonia (CAP): Streptococcus pneumoniae; Haemophilus influenzae; Mycoplasma pneumoniae; Chlamydia pneumoniae; Legionella pneumophila
• 2) By Hospital-Acquired Pneumonia (HAP): Pseudomonas aeruginosa; Staphylococcus aureus; Klebsiella pneumoniae; Acinetobacter baumannii; Enterobacter spp
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; AstraZeneca PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bacterial Pneumonia Market Characteristics

3. Bacterial Pneumonia Market Trends And Strategies

4. Bacterial Pneumonia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bacterial Pneumonia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bacterial Pneumonia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bacterial Pneumonia Market Growth Rate Analysis
• 5.4. Global Bacterial Pneumonia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bacterial Pneumonia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bacterial Pneumonia Total Addressable Market (TAM)

6. Bacterial Pneumonia Market Segmentation

• 6.1. Global Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Community-Acquired Pneumonia (CAP)
• Hospital-Acquired Pneumonia (HAP)
• 6.2. Global Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Subcutaneous
• Other Route Of Administration
• 6.3. Global Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Drugs
• 6.4. Global Bacterial Pneumonia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Bacterial Pneumonia Market, Sub-Segmentation Of Community-Acquired Pneumonia (CAP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Streptococcus pneumoniae
• Haemophilus influenzae
• Mycoplasma pneumoniae
• Chlamydia pneumoniae
• Legionella pneumophila
• 6.6. Global Bacterial Pneumonia Market, Sub-Segmentation Of Hospital-Acquired Pneumonia (HAP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pseudomonas aeruginosa
• Staphylococcus aureus
• Klebsiella pneumoniae
• Acinetobacter baumannii
• Enterobacter spp

7. Bacterial Pneumonia Market Regional And Country Analysis

• 7.1. Global Bacterial Pneumonia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bacterial Pneumonia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bacterial Pneumonia Market

• 8.1. Asia-Pacific Bacterial Pneumonia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bacterial Pneumonia Market

• 9.1. China Bacterial Pneumonia Market Overview
• 9.2. China Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bacterial Pneumonia Market

• 10.1. India Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bacterial Pneumonia Market

• 11.1. Japan Bacterial Pneumonia Market Overview
• 11.2. Japan Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bacterial Pneumonia Market

• 12.1. Australia Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bacterial Pneumonia Market

• 13.1. Indonesia Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bacterial Pneumonia Market

• 14.1. South Korea Bacterial Pneumonia Market Overview
• 14.2. South Korea Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bacterial Pneumonia Market

• 15.1. Western Europe Bacterial Pneumonia Market Overview
• 15.2. Western Europe Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bacterial Pneumonia Market

• 16.1. UK Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bacterial Pneumonia Market

• 17.1. Germany Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bacterial Pneumonia Market

• 18.1. France Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bacterial Pneumonia Market

• 19.1. Italy Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bacterial Pneumonia Market

• 20.1. Spain Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bacterial Pneumonia Market

• 21.1. Eastern Europe Bacterial Pneumonia Market Overview
• 21.2. Eastern Europe Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bacterial Pneumonia Market

• 22.1. Russia Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bacterial Pneumonia Market

• 23.1. North America Bacterial Pneumonia Market Overview
• 23.2. North America Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bacterial Pneumonia Market

• 24.1. USA Bacterial Pneumonia Market Overview
• 24.2. USA Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bacterial Pneumonia Market

• 25.1. Canada Bacterial Pneumonia Market Overview
• 25.2. Canada Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bacterial Pneumonia Market

• 26.1. South America Bacterial Pneumonia Market Overview
• 26.2. South America Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bacterial Pneumonia Market

• 27.1. Brazil Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bacterial Pneumonia Market

• 28.1. Middle East Bacterial Pneumonia Market Overview
• 28.2. Middle East Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bacterial Pneumonia Market

• 29.1. Africa Bacterial Pneumonia Market Overview
• 29.2. Africa Bacterial Pneumonia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bacterial Pneumonia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bacterial Pneumonia Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bacterial Pneumonia Market Competitive Landscape And Company Profiles

• 30.1. Bacterial Pneumonia Market Competitive Landscape
• 30.2. Bacterial Pneumonia Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Bacterial Pneumonia Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. GSK plc
• 31.3. bioMerieux SA
• 31.4. Shionogi & Co. Ltd.
• 31.5. Wockhardt Limited.
• 31.6. Zai Lab Limited
• 31.7. Innoviva Inc.
• 31.8. Eagle Pharmaceuticals Inc.
• 31.9. Basilea Pharmaceutica Ltd.
• 31.10. Paratek Pharmaceuticals Inc.
• 31.11. Cumberland Pharmaceuticals Inc.
• 31.12. Melinta Therapeutics Inc.
• 31.13. Nabriva Therapeutics plc.
• 31.14. Clarametyx Biosciences Inc.
• 31.15. Evopoint Biosciences Inc.

32. Global Bacterial Pneumonia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bacterial Pneumonia Market

34. Recent Developments In The Bacterial Pneumonia Market

35. Bacterial Pneumonia Market High Potential Countries, Segments and Strategies

• 35.1 Bacterial Pneumonia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bacterial Pneumonia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bacterial Pneumonia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료